ESC Premium Access

Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations

Event: ESC CONGRESS 2016
Topic: Lipids
Session type: Satellite Symposium
Sponsored by Pfizer, Inc.
Date: 29 August 2016
Time: 12:45 - 13:45

Session

4 presentations in this session

Welcome and introductions - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.

Speaker: Doctor C. Gibson (Boston, US)
Thumbnail

Beyond statins: understanding unmet need across the CV risk continuum.

Speaker: Professor W. Koenig (Munich, DE)
Thumbnail

Current challenges in CV risk reduction for high-risk primary and secondary prevention populations.

Speaker: Professor J. Jukema (Leiden, NL)
Speaker: Doctor C. Gibson (Boston, US)
Thumbnail

Panel discussion / Q&A - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.

Speaker: Doctor C. Gibson (Boston, US)
Speaker: Professor W. Koenig (Munich, DE)
Speaker: Professor J. Jukema (Leiden, NL)
Thumbnail

7 speakers from this session

Doctor C Michael Gibson

Harvard Medical School, Boston (United States of America)
10 presentations
0 follower

Professor Wolfgang Koenig

German Heart Center of Munich,, Munich (Germany)
20 presentations
0 follower

Professor J Wouter Jukema

Leiden University Medical Centre, Leiden (Netherlands (The))
14 presentations
0 follower

Doctor C Michael Gibson

Harvard Medical School, Boston (United States of America)
10 presentations
0 follower

Doctor C Michael Gibson

Harvard Medical School, Boston (United States of America)
10 presentations
0 follower

Professor Wolfgang Koenig

German Heart Center of Munich,, Munich (Germany)
20 presentations
0 follower

Professor J Wouter Jukema

Leiden University Medical Centre, Leiden (Netherlands (The))
14 presentations
0 follower

This platform is supported by

logo Novo Nordisk